These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 12218394)

  • 1. Forty-one near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants.
    Dowling WE; Kim B; Mason CJ; Wasunna KM; Alam U; Elson L; Birx DL; Robb ML; McCutchan FE; Carr JK
    AIDS; 2002 Sep; 16(13):1809-20. PubMed ID: 12218394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subtypes of human immunodeficiency virus type 1 and disease stage among women in Nairobi, Kenya.
    Neilson JR; John GC; Carr JK; Lewis P; Kreiss JK; Jackson S; Nduati RW; Mbori-Ngacha D; Panteleeff DD; Bodrug S; Giachetti C; Bott MA; Richardson BA; Bwayo J; Ndinya-Achola J; Overbaugh J
    J Virol; 1999 May; 73(5):4393-403. PubMed ID: 10196337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of HIV type 1 BF recombinant sequences from South America dates the origin of CRF12_BF to a recombination event in the 1970s.
    Dilernia DA; Jones LR; Pando MA; Rabinovich RD; Damilano GD; Turk G; Rubio AE; Pampuro S; Gomez-Carrillo M; Salomón H
    AIDS Res Hum Retroviruses; 2011 May; 27(5):569-78. PubMed ID: 20919926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of New HIV-1 Circulating Recombinant Forms CRF81_cpx and CRF99_BF1 in Central Western Brazil and of Unique BF1 Recombinant Forms.
    Reis MNG; Guimarães ML; Bello G; Stefani MMA
    Front Microbiol; 2019; 10():97. PubMed ID: 30804902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular cloning and phylogenetic analysis of human immunodeficiency virus type 1 subtype C: a set of 23 full-length clones from Botswana.
    Novitsky VA; Montano MA; McLane MF; Renjifo B; Vannberg F; Foley BT; Ndung'u TP; Rahman M; Makhema MJ; Marlink R; Essex M
    J Virol; 1999 May; 73(5):4427-32. PubMed ID: 10196340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanopore Sequencing for Characterization of HIV-1 Recombinant Forms.
    Mori M; Ode H; Kubota M; Nakata Y; Kasahara T; Shigemi U; Okazaki R; Matsuda M; Matsuoka K; Sugimoto A; Hachiya A; Imahashi M; Yokomaku Y; Iwatani Y
    Microbiol Spectr; 2022 Aug; 10(4):e0150722. PubMed ID: 35894615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tracking HIV-1 recombination to resolve its contribution to HIV-1 evolution in natural infection.
    Song H; Giorgi EE; Ganusov VV; Cai F; Athreya G; Yoon H; Carja O; Hora B; Hraber P; Romero-Severson E; Jiang C; Li X; Wang S; Li H; Salazar-Gonzalez JF; Salazar MG; Goonetilleke N; Keele BF; Montefiori DC; Cohen MS; Shaw GM; Hahn BH; McMichael AJ; Haynes BF; Korber B; Bhattacharya T; Gao F
    Nat Commun; 2018 May; 9(1):1928. PubMed ID: 29765018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pervasive and non-random recombination in near full-length HIV genomes from Uganda.
    Grant HE; Hodcroft EB; Ssemwanga D; Kitayimbwa JM; Yebra G; Esquivel Gomez LR; Frampton D; Gall A; Kellam P; de Oliveira T; Bbosa N; Nsubuga RN; Kibengo F; Kwan TH; Lycett S; Kao R; Robertson DL; Ratmann O; Fraser C; Pillay D; Kaleebu P; Leigh Brown AJ
    Virus Evol; 2020 Jan; 6(1):veaa004. PubMed ID: 32395255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequence Notes: Near Full-Length Genome Analysis of the First-Reported HIV-1 Circulating Recombinant Form (CRF)_10CD in Uganda.
    Bbosa N; Holzmayer V; Ssemwanga D; Downing R; Ssekagiri A; Anderson M; Rodgers MA; Kaleebu P; Cloherty G
    AIDS Res Hum Retroviruses; 2024 Jul; ():. PubMed ID: 38959121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Near full-length HIV-1 subtype B sequences from the early South African epidemic, detecting a BD unique recombinant form (URF) from a sample in 1985.
    Obasa AE; Engelbrecht S; Jacobs GB
    Sci Rep; 2019 Apr; 9(1):6227. PubMed ID: 30996293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adaptation of an R5 Simian-Human Immunodeficiency Virus Encoding an HIV Clade A Envelope with or without Ablation of Adaptive Host Immunity: Differential Selection of Viral Mutants.
    Zhou M; Humbert M; Mukhtar MM; Scinto HB; Vyas HK; Lakhashe SK; Byrareddy SN; Maurer G; Thorat S; Owuor J; Lai Z; Chen Y; Griffiths A; Chenine AL; Gumber S; Villinger F; Montefiori D; Ruprecht RM
    J Virol; 2019 May; 93(9):. PubMed ID: 30760566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 Subtypes and 5'LTR-Leader Sequence Variants Correlate with Seroconversion Status in Pumwani Sex Worker Cohort.
    Sampathkumar R; Scott-Herridge J; Liang B; Kimani J; Plummer FA; Luo M
    Viruses; 2017 Dec; 10(1):. PubMed ID: 29295533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania.
    Billings E; Sanders-Buell E; Bose M; Kijak GH; Bradfield A; Crossler J; Arroyo MA; Maboko L; Hoffmann O; Geis S; Birx DL; Kim JH; Michael NL; Robb ML; Hoelscher M; Tovanabutra S
    AIDS Res Hum Retroviruses; 2017 Apr; 33(4):373-381. PubMed ID: 27841669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Number and Complexity of Pure and Recombinant HIV-1 Strains Observed within Incident Infections during the HIV and Malaria Cohort Study Conducted in Kericho, Kenya, from 2003 to 2006.
    Billings E; Sanders-Buell E; Bose M; Bradfield A; Lei E; Kijak GH; Arroyo MA; Kibaya RM; Scott PT; Wasunna MK; Sawe FK; Shaffer DN; Birx DL; McCutchan FE; Michael NL; Robb ML; Kim JH; Tovanabutra S
    PLoS One; 2015; 10(8):e0135124. PubMed ID: 26287814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-infected sex workers with beneficial HLA-variants are potential hubs for selection of HIV-1 recombinants that may affect disease progression.
    Chang CH; Kist NC; Stuart Chester TL; Sreenu VB; Herman M; Luo M; Lunn D; Bell J; Plummer FA; Ball TB; Katzourakis A; Iversen AK
    Sci Rep; 2015 Jun; 5():11253. PubMed ID: 26082240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV diversity and drug resistance from plasma and non-plasma analytes in a large treatment programme in western Kenya.
    Kantor R; DeLong A; Balamane M; Schreier L; Lloyd RM; Injera W; Kamle L; Mambo F; Muyonga S; Katzenstein D; Hogan J; Buziba N; Diero L
    J Int AIDS Soc; 2014; 17(1):19262. PubMed ID: 25413893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombination pattern reanalysis of some HIV-1 circulating recombination forms suggest the necessity and difficulty of revision.
    Jia L; Li L; Li H; Liu S; Wang X; Bao Z; Li T; Zhuang D; Liu Y; Li J
    PLoS One; 2014; 9(9):e107349. PubMed ID: 25203725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of HIV-1 protease gene reveals frequent multiple infections followed by recombination among drug treated individuals living in São Paulo and Santos, Brazil.
    Nunes ER; Zukurov JP; Maricato JT; Sucupira MC; Diaz RS; Janini LM
    PLoS One; 2014; 9(1):e84066. PubMed ID: 24404149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous detection of major drug resistance mutations in the protease and reverse transcriptase genes for HIV-1 subtype C by use of a multiplex allele-specific assay.
    Zhang G; Cai F; Zhou Z; DeVos J; Wagar N; Diallo K; Zulu I; Wadonda-Kabondo N; Stringer JS; Weidle PJ; Ndongmo CB; Sikazwe I; Sarr A; Kagoli M; Nkengasong J; Gao F; Yang C
    J Clin Microbiol; 2013 Nov; 51(11):3666-74. PubMed ID: 23985909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The HIV-1 epidemic: low- to middle-income countries.
    Shao Y; Williamson C
    Cold Spring Harb Perspect Med; 2012 Mar; 2(3):a007187. PubMed ID: 22393534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.